Transgene Biotek Ltd
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|
| Revenue | 0.06 | 0.20 | 0.05 |
| Operating Expense | 0.12 | 0.33 | 0.11 |
| Net Profit | -0.39 | -0.46 | -0.37 |
| Net Profit Margin | -650.00% | -230.00% | -740% |
| Earning Per Share | -0.05 | -0.06 | -0.05 |
| EBIDTA | -0.06 | -0.13 | -0.05 |
| Effective Tax Rate | -0% | -0% | -0% |
Particulars
Jun 2026
Revenue0.06
Operating Expense0.12
Net Profit-0.39
Net Profit Margin-650.00
Earning Per Share-0.05
EBIDTA-0.06
Effective Tax Rate-0
